FY24 sbir phase II RD contract - topic 442 boston cell standards, INC.
Active Definitive Contract Awarded Last action
- Contract number
- 75N91024C00087
- Awardee
-
Boston Cell Standards Inc. UEI HA17F32KXEV8
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,995,119
Award facts
- Contract value 100% obligated
- $1,995,119.00 Current and potential, with all options
- Completion date 93% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 11 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Sharon, MA 02067, USA
- Research
- SBIR Program Phase II Action
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $1,995,119 |
About this award
The National Cancer Institute awarded a $1.995 million definitive contract to Boston Cell Standards Inc., a small business, for FY24 SBIR Phase II research and development on September 16, 2024, under a total small business set-aside. The award extends the period of performance from September 16, 2024 through January 15, 2027 at no additional cost to the government.
The contract addresses Topic 442 Boston Cell Standards, focused on developing quantitative traceable reference materials and standardization tools for cancer research and clinical immunohistochemistry. Place of performance is Sharon, Massachusetts.
Under Service Contract Inventory reporting, Boston Cell Standards invoiced $998 thousand in FY2025 with 4.0 FTEs and self-performed all reported hours. FY2024 activity totaled 0.2 FTEs and 376 contractor hours. The contract carries firm fixed-price pricing.
Quick answers
Who was awarded contract 75N91024C00087?
75N91024C00087 was awarded to Boston Cell Standards Inc. by National Cancer Institute (National Institutes of Health) on September 8, 2024.
How much is contract 75N91024C00087 worth?
The government has obligated $1,995,119 on 75N91024C00087.
Was contract 75N91024C00087 competed?
The extent of competition for 75N91024C00087 was full and open competition after exclusion of sources. The government received 11 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award